Veru (VERU) Deferred Taxes (2010 - 2025)
Veru (VERU) posted quarterly Deferred Taxes of -$1.0 for Q3 2025, down 100.0% year-over-year from $139251.0 in Q3 2024, and up 99.95% quarter-over-quarter from -$1915.0 in Q4 2024.
Veru (VERU) Deferred Taxes (2010 - 2025) Analysis & Trends
Veru (VERU) has reported Deferred Taxes for 16 consecutive years, with -$1.0 the latest figure, recorded in Q3 2025.
- In Q3 2025, Deferred Taxes fell 100.0% year-over-year to -$1.0; the TTM figure through Mar 2026 stood at -$1.0 (down 100.0% YoY), while the FY2025 annual figure was -$1916.0, down 100.52% from the prior year.
- Deferred Taxes rose to -$1.0 in Q3 2025 per VERU's latest filing, from -$1915.0 in the prior quarter.
- Across five years, Deferred Taxes topped out at $156439.0 in Q2 2024 and bottomed at -$2.9 million in Q2 2021.
- Historically, Deferred Taxes has averaged -$189912.0 across 5 years, with a median of -$1915.0 in 2024.
- Annual changes were most pronounced in 2021 — Deferred Taxes plunged 396825.2% — and 2024, when it surged 666.38%.
- Veru's Deferred Taxes stood at $93421.0 in 2021, then plunged by 211.13% to -$103819.0 in 2022, then grew by 21.7% to -$81286.0 in 2023, then jumped by 97.64% to -$1915.0 in 2024, then surged by 99.95% to -$1.0 in 2025.
- Business Quant data shows VERU's Deferred Taxes at -$1.0 in Q3 2025, -$1915.0 in Q4 2024, and $139251.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.03 Bn | 131.18 Bn | 2.84 Bn | -69.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.64 Bn | 77.64 Bn | 3.93 Bn | 194.40 Mn |
| 3 | Argenx Se | 64.93 Bn | 59.75 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.93 Bn | 52.80 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.95 Bn | 36.86 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.51 Bn | 28.20 Bn | 992.69 Mn | 2.66 Mn |
| 7 | BioNTech SE | 28.00 Bn | 9.60 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.29 Bn | 26.45 Bn | - | - |
| 10 | Veru | 60.39 Mn | 34.60 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -1.00 |
| Dec 31, 2024 | -1,915.00 |
| Sep 30, 2024 | 139,251.00 |
| Jun 30, 2024 | 156,439.00 |
| Mar 31, 2024 | 152,778.00 |
| Dec 31, 2023 | -81,286.00 |
| Sep 30, 2023 | 149,746.00 |
| Jun 30, 2023 | -27,621.00 |
| Mar 31, 2023 | -81,732.00 |
| Dec 31, 2022 | -103,819.00 |
| Sep 30, 2022 | 57,189.00 |
| Jun 30, 2022 | 13,852.00 |
| Mar 31, 2022 | -88,256.00 |
| Dec 31, 2021 | 93,421.00 |
| Sep 30, 2021 | -656,270.00 |
| Jun 30, 2021 | -2.94 Mn |
| Mar 31, 2021 | -6,579.00 |
| Dec 31, 2020 | 37,502.00 |
| Sep 30, 2020 | -1.06 Mn |
| Jun 30, 2020 | 742.00 |